Skip to main content

Table 3 Mean Ocular Perfusion Pressure (MOPP) at Baseline and at Various Times after Intravitreal Injection

From: Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab

MOPP range (mmHg)

No. (%)

Baseline

Immediately

30 min

24 h

1 week

0–9

     

10–19

 

14 (21.6 %)

   

20–29

 

30 (46.2 %)

1 (1.5 %)

2 (3.1 %)

5 (7.7 %)

30–39

9 (13.8 %)

19 (29.2 %)

7 (10.8 %)

1 (1.5 %)

43 (66.1 %)

40–49

36 (55.4 %)

1 (1.5 %)

35 (53.8 %)

39 (60.0 %)

15 (23.1 %)

50–59

18 (27.7 %)

1 (1.5 %)

22 (33.8 %)

22 (33.8 %)

2 (3.1 %)

60–69

2 (3.1 %)

  

1 (1.5 %)